Acadian Asset Management
FOMX

Acadian Asset Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Acadian Asset Management’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,313
Closed -$9K – 1584
2016
Q1 		$9K Sell
1,313
-62,613
-98% -$404K ﹤0.01% 1209
2015
Q4 		$518K Sell
63,926
-219,663
-77% -$1.64M ﹤0.01% 805
2015
Q3 		$2.08M Sell
283,589
-77,196
-21% -$787K 0.01% 545
2015
Q2 		$3.7M Buy
360,785
+315,093
+690% +$3.48M 0.02% 478
2015
Q1 		$422K Buy
+45,692
New +$409K ﹤0.01% 797

Other funds holding FOMX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Acadian Asset Management's FOMX Position: Q2 2016 in Review

Acadian Asset Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q2 2016, closing a stake of 1,313 shares — an estimated $9K sold.

Acadian Asset Management first reported a position in FOMX in Q1 2015 and held it in 5 quarters. The position peaked at $3.7M in Q2 2015. 56 funds tracked by Wall St. Rank hold FOMX as of Q2 2016.

  • Acadian Asset Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q2 2016 after selling out during the quarter.
  • Acadian Asset Management sold 1,313 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q2 2016, an estimated $9K.
  • Acadian Asset Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2015 and held it in 5 quarters.
  • Acadian Asset Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $3.7M in Q2 2015.
  • 56 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q2 2016.

Based on Acadian Asset Management's 13F filing for Q2 2016, filed 19 Jul 2016.